Source: U.S. Food and Drug Administration
Recommendations and guidance regarding the special considerations that researchers should consider when conducting clinical studies for preventive HIV vaccines in pediatric populations.
Guidance for health care providers who are treating HIV-infected people who have recently been displaced from disaster areas and have not yet secured HIV care in the areas where they have relocated.
Guidelines for health care providers on preventing and treating opportunistic infections (OIs) in HIV-exposed and HIV-infected infants, children, and adolescents.
Web-based guidelines for treating HIV-infected infants, children, and adolescents, including information on clinical monitoring, initiation of treatment, pediatric-specific drugs, and managing complications.
Poster that was featured at the 2013 mHealth Summit that describes the evolution of the dissemination of the HIV medical practice guidelines.